HBI
58
3
SBUX
37
-2
MO
60
-2
VRTX
47
-6
NI
72
4
STI
45
26
VMC
53
-4
INTC
41
4
GLW
45
-3
CHD
54
4
DLTR
38
-4
AON
54
2
RHI
57
-6
CSCO
58
-2
UNH
57
-2
JNJ
41
3
ADBE
47
-9
KSS
39
-7
GE
61
-3
WMB
68
2
HBI
58
3
SBUX
37
-2
MO
60
-2
VRTX
47
-6
NI
72
4
STI
45
26
VMC
53
-4
INTC
41
4
GLW
45
-3
CHD
54
4
DLTR
38
-4
AON
54
2
RHI
57
-6
CSCO
58
-2
UNH
57
-2
JNJ
41
3
ADBE
47
-9
KSS
39
-7
GE
61
-3
WMB
68
2
Financhill
Back

Duluth Holdings Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

DLTH
Duluth Holdings

Last Price:
3.51
Seasonality Move:
-11.78%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
Duluth Holdings (DLTH) is a Sell

Is Duluth Holdings a Buy, Sell or Hold?

  • The current Duluth Holdings [DLTH] share price is $3.50. The Score for DLTH is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • DLTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DLTH Stock Price Chart

What is Duluth Holdings's stock price today?

  • The Duluth Holdings share price today is $3.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DLTH is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DLTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 39 Sell
Chaikin Money Flow: -35804 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.66 - 3.94) Sell
Bollinger Bands (100): (3.47 - 3.93) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DLTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.71 Sell
20-day SMA: 3.76 Sell
50-day SMA: 3.81 Sell
200-day SMA: 4.08 Sell
8-day EMA: 3.68 Sell
20-day EMA: 3.74 Sell
50-day EMA: 3.76 Sell
200-day EMA: 4.16 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Duluth Holdings Earnings Growth & DLTH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.01 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Duluth Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):